Literature DB >> 7418950

Study of migraine and the treatment of acute attacks in industry.

A Jones, C Harrop.   

Abstract

A simple study of migraine was undertaken in an industrial setting to identify facts about the condition of migraine which had previously been unrecorded in industry. The study was based on a definition of migraine encompassing headache accompanied by visual or gastro-intestinal disturbances. During the period from April 1979 to December 1979 there were 111 separate incidents reported to this department, with 281 working days lost in this period, which would give an average annual loss of 420 working days through migraine. Approximately 6% of the work-force were seen to be affected by migraine. Using a simple treatment it was possible to return the majority of the work-force to the place of work within 1 hour, with no subsequent problem caused to their health, either through migraine or accident.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7418950     DOI: 10.1177/030006058000800503

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  5 in total

1.  Healthcare resource and lost labour costs of migraine headache in the US.

Authors:  J T Osterhaus; D L Gutterman; J R Plachetka
Journal:  Pharmacoeconomics       Date:  1992-07       Impact factor: 4.981

2.  The migraine work and productivity loss questionnaire: concepts and design.

Authors:  D J Lerner; B C Amick; S Malspeis; W H Rogers; N C Santanello; W C Gerth; R B Lipton
Journal:  Qual Life Res       Date:  1999-12       Impact factor: 4.147

3.  A plain man's guide to the management of migraine.

Authors:  J N Blau
Journal:  Br Med J (Clin Res Ed)       Date:  1982-04-10

4.  Headaches in civil servants: effect on work and leisure.

Authors:  M L Espir; J Thomason; J N Blau; Z Kurtz
Journal:  Br J Ind Med       Date:  1988-05

Review 5.  Metoclopramide. An updated review of its pharmacological properties and clinical use.

Authors:  R A Harrington; C W Hamilton; R N Brogden; J A Linkewich; J A Romankiewicz; R C Heel
Journal:  Drugs       Date:  1983-05       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.